Opinion|Videos|May 22, 2024

Overview of Clinical Trials for New Imaging Options for Kidney Cancer

Author(s)Neal Shore, MD, FACS, Brian M. Shuch, MD

Urologists review clinical trials investigating new imaging options in kidney cancer, including the ZIRCON study looking at girentuximab.

Episodes in this series

Video 1 - "A Growing Incidence of Renal Masses"

EP. 1 A Growing Incidence of Renal Masses

Video 2 - "Diagnostic Tests for Kidney Cancer"

EP. 2 Diagnostic Tests for Kidney Cancer

EP. 3 Limitations of Conventional Imaging for Assessing Renal Masses

EP. 3 Limitations of Conventional Imaging for Assessing Renal Masses

Video 4 - "The Role of a Multidisciplinary Team in Managing Kidney Cancer"

EP. 4 The Role of a Multidisciplinary Team in Managing Kidney Cancer

Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer

EP. 5 Staging and Treatment Decisions for Kidney Cancer

Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer

EP. 6 Advances in Imaging for Kidney Cancer Diagnosis and Management

Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer

EP. 7 Overview of Clinical Trials for New Imaging Options for Kidney Cancer

Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer

EP. 8 Potential Impact of PET/CT Imaging on Improving Patient Care

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

FDA updates in urology: August 2026

ByHannah Clarke

September 1st 2026

FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent

ByHannah Clarke

August 19th 2026

Radium-223 fails to improve skeletal event-free survival in metastatic RCC

ByHannah Clarke

August 18th 2026

Published LITESPARK-011 data show PFS benefit with belzutifan plus lenvatinib in ccRCC

ByHannah Clarke

August 13th 2026

Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab

ByElizabeth Nally, MBBS

August 7th 2026

Latest CME

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

AI-generated profiles impersonate female urologists to market ED products online

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

Doublet or triplet? Urologists weighs in on mCSPC options

John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC

Alternative BCG strains may help address ongoing supply challenges in NMIBC